Affluent Medical

Company Description

---

ffluent Medical is committed to offering the best available therapies worldwide for hitherto largely unmet needs in terms of widespread and critical diseases. Millions of patients around the world are suffering and cannot always find optimal therapies.

Affluent Medical focuses on breakthrough medical devices using a new approach. Deep understanding of the physiology helps us to design a new generation of minimally invasive prostheses with the aim of mimicking anatomy and restoring native physiology for critical functions.

Our approach heralds a new era for cardiovascular and urological therapies. The combination of our highly talented team and deep expertise will enable us to lead this major shift toward more physiological therapies.

Affluent Medical reached in 2020 another key milestone of its development ; all its products are now in a clinical phase.

Year founded

---

2011

Headcount

---

48

Headquarters

---

Les Pléiades III - Bâtiment B 320 Avenue Archimède, 13100 Aix-en-Provence – France

Shares outstanding

---

18,163,802

IPO

---

June 14, 2021

Stock exchange(s)

---

Euronext Paris